Evidence map›Paper›PMID 21541272›Full record

ArticleMolecular vision2011

Hematologic biomarkers in childhood cataracts.

O Wussuki-Lior, A Abu-Horowitz, I Netzer, Z Almer, Y Morad, Y Goldich, V Yahalom, El Pras, Er Pras

Open access · greenAbstract read
In one paragraph

Article in Molecular vision, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Pleiotropic effect of a novel mutation inHuman genome variation · 2017
    Article
  5. Article
  6. Epidemiology and molecular genetics of congenital cataracts.International journal of ophthalmology · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

O Wussuki-LiorDepartment of Ophthalmology, Assaf Harofeh Medical Center, Zerifin, Israel.
A Abu-Horowitz
I Netzer
Z Almer
Y Morad
Y Goldich
V Yahalom
El Pras
Er Pras
Assaf Harofeh Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo date, more than thirty nine genetic loci have been associated with congenital cataracts. Despite this progress, current diagnostic techniques are insufficient for unraveling the underlying genetic defect in sporadic patients and small families. In the present manuscript we demonstrate the contribution of routine laboratory tests in the search for genetic defects of childhood cataracts.

methodsTwo families with congenital cataracts and hematologic findings that included hyperferritinemia and the "ii" blood type underwent detailed ophthalmologic and clinical examinations. Mutation analysis of the ferritin light chain (FTL) and glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (GCNT2) genes was performed in the two families, respectively.

resultsIn the family with the "ii" blood group we found a novel GCNT2 mutation c.G935A (p.G312D) in the cataract patients, while in the family with hyperferritinemia cataract syndrome we identified a G→C heterozygous mutation at position +32 of FTL.

conclusionsHematologic biomarkers may simplify the search for the underlying molecular defect in families with congenital cataract.

Indexed as

AdultApoferritinsBiomarkersBlood Group AntigensCataractChildConsanguinityDNA Mutational AnalysisFemaleGenetic LinkageGenetic Predisposition to DiseaseHumansIron Metabolism DisordersIsraelLens, CrystallineMaleApoferritinsBiomarkersBlood Group AntigensFTL protein, humanN-acetylglucosaminyltransferase IGnTN-Acetylglucosaminyltransferases

Identifiers

PMID21541272
PMCPMC3084226
OpenAlexW1573462051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.